* Tetraphase Pharmaceuticals - entered into amendment no. 1 to its controlled equity offering(sm)sales agreement dated jan 17

* Tetraphase Pharmaceuticals - sole effect of amendment is to increase offering price of co's shares which co may issue up to $80 million from $40 million Source text for Eikon: Further company coverage: